High complete remission rate and promising outcome by combination of imatinib and chemotherapy for newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia: a phase II study by the Japan Adult Leukemia Study Group.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples